INCREASED FIBRINOLYTIC-ACTIVITY IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS OPERATION

被引:48
作者
KUCUK, O
KWAAN, HC
FREDERICKSON, J
WADE, L
GREEN, D
机构
[1] NORTHWESTERN UNIV,SCH MED,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60611
[2] NORTHWESTERN UNIV,SCH MED,DEPT MED,HEMATOL SECT,CHICAGO,IL 60611
[3] NORTHWESTERN UNIV,SCH MED,DEPT CARDIOTHORAC SURG,HEMATOL SECT,CHICAGO,IL 60611
[4] NORTHWESTERN UNIV,SCH MED,DEPT CARDIOTHORAC SURG,MED ONCOL SECT,CHICAGO,IL 60611
[5] NORTHWESTERN UNIV,SCH MED,CTR CANC,CHICAGO,IL 60611
[6] NORTHWESTERN UNIV,SCH MED,ATHEROSCLEROSIS PROGRAM,CHICAGO,IL 60611
[7] VET ADM LAKESIDE HOSP,CHICAGO,IL
关键词
D O I
10.1002/ajh.2830230306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:223 / 229
页数:7
相关论文
共 22 条
[1]  
BACHMAN F, 1973, J THORAC CARDIOVASC, V70, P76
[2]  
BICK R L, 1976, Seminars in Thrombosis and Hemostasis, V3, P59
[3]  
CARROLL RC, 1981, BLOOD, V57, P44
[4]  
DONALDSON VH, 1982, BLOOD, V60, P121
[5]  
FEARNLEY GR, 1957, CLIN SCI, V16, P645
[6]  
FRIBERGER P, 1979, CHROMOGENIC PEPTIDE, pCH13
[7]  
GRALNICK HR, 1975, J THORAC CARDIOVASC, V70, P350
[8]  
HARKER LA, 1980, BLOOD, V56, P824
[9]  
LAMBERT C J, 1976, Seminars in Thrombosis and Hemostasis, V3, P90
[10]  
LO R, 1958, CLIN SCI, V17, P499